Literature DB >> 9284618

[Protective effect of nitric oxide on ischemic retina].

N Imai1, Y Tsuyama, K Murayama, E Adachi-Usami.   

Abstract

Nitric oxide (NO) is a free radical and was regarded as noxious to life. But recent studies show that NO is an important substance for transcellular signal transduction. It also seems to act as a neurotransmitter in the nervous system. In ischemic nerve tissue a release of glutamate is one of the critical factors that increase neuronal death, and some experiments suggest that NO may be involved in this process. Here we provide evidence that NO provides neuroprotection in ischemic retinas in vivo. Albino rabbits' eyes were subjected to 60 minutes of ischemia by raising intraocular pressure. Before ischemia the eyes were treated intravitreously with the NO-precursor L-arginine, the NO synthase-inhibitor nitro-L-arginine methyl ester hydrochloride (L-NAME), the NO-donor sodium nitroprusside (SNP), or solvent only. The amplitude of the b-wave was measured and the recovery ratio of the b-wave was analyzed hourly after reperfusion. The recovery ratio of b-wave in the eyes with L-arginine and with SNP increased more rapidly than in the controls, while the recovery ratio in the eyes with L-NAME increased in a way similar to that of the controls. These results suggest that NO plays a neuroprotective role in ischemic retina. It may be involved with S-nitrosylation of some proteins, including one of the glutamate receptors, the N-methyl-D-aspertate (NMDA) receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284618

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  4 in total

1.  NO donors inhibit Na,K-ATPase activity by a protein kinase G-dependent mechanism in the nonpigmented ciliary epithelium of the porcine eye.

Authors:  Mohammad Shahidullah; Nicholas A Delamere
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

Review 2.  S-Nitrosylation Regulates Cell Survival and Death in the Central Nervous System.

Authors:  Yoshiki Koriyama; Ayako Furukawa
Journal:  Neurochem Res       Date:  2017-05-18       Impact factor: 3.996

3.  BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats.

Authors:  Mirna Zlatar; Antonio Kokot; Lovorka Batelja Vuletic; Sanja Masnec; Tamara Kralj; Marija Milkovic Perisa; Ivan Barisic; Bozo Radic; Kristina Milanovic; Domagoj Drmic; Sven Seiwerth; Predrag Sikiric
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

Review 4.  Current Concepts in the Biochemical Mechanisms of Glaucomatous Neurodegeneration.

Authors:  Syed Shoeb Ahmad; Shuaibah Abdul Ghani; Theodora Hemalata Rajagopal
Journal:  J Curr Glaucoma Pract       Date:  2013-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.